A
Alex Rovira
Researcher at Autonomous University of Barcelona
Publications - 398
Citations - 23171
Alex Rovira is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Multiple sclerosis & Magnetic resonance imaging. The author has an hindex of 74, co-authored 356 publications receiving 19586 citations. Previous affiliations of Alex Rovira include Hebron University.
Papers
More filters
Journal ArticleDOI
Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies
TL;DR: No cause-effect relationship has been demonstrated in patients between brain gadolinium exposure and clinical consequences specific to neurological toxicity, as confirmed by preclinical animal and human (MR imaging and autopsy) studies.
Journal Article
Radiologic Findings in Two Cases of Acute Schmörl's Nodes
TL;DR: Two cases of atypical acute Schmörl's nodes are described, one benign, the other on a tumoral vertebra, showing a decreased vertebral T1 signal and a slightly increased T2 signal that are indistinguishable from tumoral disease or inflammatory lesions.
Journal ArticleDOI
Specificity of Barkhof criteria in predicting conversion to multiple sclerosis when applied to clinically isolated brainstem syndromes.
Jaume Sastre-Garriga,Mar Tintoré,Alex Rovira,Carlos Nos,Jordi Río,Alan J. Thompson,Xavier Montalban +6 more
TL;DR: The infratentorial lesion criterion is responsible for the lower specificity of Barkhof criteria in CISB, as compared with specificity in other CIS, in which all 4 criteria demonstrate dissemination in space.
Journal ArticleDOI
A multicentre study of motor functional connectivity changes in patients with multiple sclerosis.
Paola Valsasina,Maria A. Rocca,Martina Absinta,Maria Pia Sormani,Laura Mancini,Nicola De Stefano,Alex Rovira,Achim Gass,Christian Enzinger,Frederik Barkhof,Christiane Wegner,Paul M. Matthews,Paul M. Matthews,Massimo Filippi +13 more
TL;DR: The results provide further evidence for increased bihemispheric contributions to motor control in patients with MS relative to healthy controls and suggest that multicentre fMRI studies of FC changes are possible, and provide a potential imaging biomarker for use in experimental therapeutic studies directed at enhancing adaptive plasticity in the disease.
Journal ArticleDOI
Predictive value of early brain atrophy on response in patients treated with interferon β.
Francisco Pérez-Miralles,Jaume Sastre-Garriga,Angela Vidal-Jordana,Jordi Río,Cristina Auger,Deborah Pareto,Mar Tintoré,Alex Rovira,Xavier Montalban +8 more
TL;DR: At the patient level, whole-brain and white matter volume changes in the first year of interferon β therapy are predictive of subsequent clinical evolution under treatment.